{"name": "Gliknik",
 "permalink": "gliknik",
 "crunchbase_url": "http://www.crunchbase.com/company/gliknik",
 "homepage_url": "http://www.gliknik.com",
 "blog_url": "",
 "blog_feed_url": "http://www.gliknik.com/news/",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "202-346-1100",
 "description": "",
 "created_at": "Fri Jan 07 02:15:19 UTC 2011",
 "updated_at": "Wed May 29 04:18:36 UTC 2013",
 "overview": "\u003Cp\u003EGliknik, Inc., a biopharmaceuticals company, develops therapies for patients with cancer and immune disorders. Its Immunomodulator Platform involves in off-the-shelf peptide drugs that increase CD4, CD8, and antibody immune responses against cancer; Stradomer Platform produces drugs designed to mimic the eficacy of pooled human intravenous immunoglobulin; and Stradobody Platform produces compounds that are similar to moncolonal antibodies for tumor cell killing. The company was founded in 2007 and is based in Baltimore, Maryland.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       58],
      "assets/images/resized/0011/6436/116436v1-max-150x150.jpg"],
     [[242,
       95],
      "assets/images/resized/0011/6436/116436v1-max-250x250.jpg"],
     [[242,
       95],
      "assets/images/resized/0011/6436/116436v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "David",
      "last_name": "S. Block",
      "permalink": "david-s-block",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$38.2M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2011/01/gliknik-raises-35m-in-equity-financing.html",
    "source_description": "Gliknik Raises $3.5M in Equity Financing",
    "raised_amount": 3500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 1,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org": null,
       "person":
        {"first_name": "Joel",
         "last_name": "B. Braunstein",
         "permalink": "joel-b-braunstein",
         "image": null}}]},
   {"round_code": "b",
    "source_url": "http://www.finsmes.com/2012/10/gliknik-raises-4-9m-series-funding.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Gliknik Raises $4.9M in Series B Funding",
    "raised_amount": 4900000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 10,
    "funded_day": 8,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Baxter Ventures",
         "permalink": "baxter-ventures",
         "image":
          {"available_sizes":
            [[[150,
               45],
              "assets/images/resized/0025/9384/259384v1-max-150x150.png"],
             [[153,
               46],
              "assets/images/resized/0025/9384/259384v1-max-250x250.png"],
             [[153,
               46],
              "assets/images/resized/0025/9384/259384v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020130513e95dqm2j9\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020130513e95dqm2j9%26from%3dalert%26pid%3d32",
    "source_description": "Gliknik Increases Funding to $20M, Preps Autoimmune Disease Drug for Trials",
    "raised_amount": 20000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 5,
    "funded_day": 13,
    "investments":
     []},
   {"round_code": "partial",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1411569/000141156913000001/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 9825014.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 26,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "801 W. Baltimore Street",
    "address2": "Suite 501A",
    "zip_code": "21201",
    "city": "Baltimore",
    "state_code": "MD",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        92],
       "assets/images/resized/0026/8380/268380v1-max-150x150.png"],
      [[250,
        153],
       "assets/images/resized/0026/8380/268380v1-max-250x250.png"],
      [[450,
        276],
       "assets/images/resized/0026/8380/268380v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}